A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 53
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : GRE
Long Form : glycopeptide-resistant enterococci
No. Year Title Co-occurring Abbreviation
2018 Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017. ANRESIS, CR, ESC-R, IQR, MRSA, NH
2016 Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France. CPE, HDRO
2014 Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes. ---
2014 Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital. Q-D
2013 Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. CPs, CSM, RTP, TAT
2011 Control of a regional outbreak of vanA glycopeptide-resistant Enterococcus faecium, Eastern France, 2004-2009. ---
2011 In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008. CFT, CNR-Enc, DPT, LZD, Q-D, TGC, TLV
2011 Presence of glycopeptide-encoding plasmids in enterococcal isolates from food and humans in Denmark. MGE
2011 Resistance patterns and occurrence of virulence determinants among GRE strains in southwestern Poland. MICs
10  2011 [Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?]. ---
11  2010 Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents. CDI, MRSA
12  2010 Molecular characterization of glycopeptide-resistant enterococci from hospitals of the picardy region (france). GREfm, GREfs, MLST, PFGE, STs
13  2010 vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. ---
14  2009 A prospective study of the impact of colonization following hospital admission by glycopeptide-resistant Enterococci on mortality during a hospital outbreak. CI
15  2009 In vitro inhibition of vancomycin-susceptible and vancomycin-resistant Enterococcus faecium and E. faecalis in the presence of citrus essential oils. CFU, EO, HCAI, MIC, MID
16  2008 [Glycopeptide-resistant Enterococcus outbreak in an ICU with simultaneous circulation of two different clones]. ICU, PFGE
17  2007 N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. GISA
18  2007 VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinants. PFGE
19  2007 [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier]. ICU
20  2006 Clinical glycopeptide-resistant enterococci isolated from patients after solid organ transplantation. PCR
21  2006 Guidelines for the control of glycopeptide-resistant enterococci in hospitals. HIS, ICNA
22  2006 Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 years after the ban on avoparcin. GREF, PSK
23  2005 A survey of antimicrobial resistance in a tertiary referral hospital in the United Arab Emirates. MRSA, UAE
24  2005 Antibiotics and gastrointestinal colonization by vancomycin-resistant enterococci. ---
25  2005 Identification of glycopeptide-resistant enterococci by VITEK 2 system and conventional and real-time polymerase chain reaction. mPCR
26  2005 The need for new therapeutic agents: what is the pipeline? MRSA
27  2004 Debate-guidelines for control of glycopeptide-resistant enterococci (GRE) have not yet worked. ---
28  2003 Evaluation of selective and enrichment media for isolation of glycopeptide-resistant enterococci from faecal specimens. EB, ITU, VEB
29  2003 Genetic characterization of glycopeptide-resistant enterococci of human and animal origin from mixed pig and poultry farms. ---
30  2003 Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). APAC, Ef, Efm, EU, LA, NA
31  2003 Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. CoNS, SXT
32  2003 Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. MIC
33  2003 The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species. MH, MRSA
34  2002 First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia. ---
35  2002 Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice. ---
36  2002 The epidemiology of glycopeptide-resistant enterococci on a haematology unit--analysis by pulsed-field gel electrophoresis. PFGE
37  2001 Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci. ---
38  2001 Human infections caused by glycopeptide-resistant Enterococcus spp: are they a zoonosis? ---
39  2000 Characterization of glycopeptide-resistant enterococcus faecium (GRE) from broilers and pigs in Denmark: genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides. PFGE
40  2000 Control of glycopeptide-resistant enterococci in an oncology unit. FN
41  2000 Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa. ---
42  2000 Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. ---
43  2000 Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. ---
44  1999 An Update on the Emergence of Glycopeptide Resistance in Enterococci. ---
45  1999 Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients. ---
46  1999 Detection of glycopeptide-resistant enterococci in routine diagnostic faeces specimens. ---
47  1999 Validity of screening procedures for glycopeptide-resistant enterococci. NCCLS
48  1999 Variation in structure and location of VanA glycopeptide resistance elements among enterococci from a single patient. ---
49  1998 Characterization of glycopeptide-resistant enterococci from a Swiss hospital. ---
50  1998 Glycopeptide-resistant enterococci: a decade of experience. ---
51  1998 Long PCRs of transposons in the structural analysis of genes encoding acquired glycopeptide resistance in enterococci. ---
52  1997 Comparison of agar-based media for primary isolation of glycopeptide-resistant enterococci. BAP, KAA
53  1996 Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. ---